Evaluation of oral anti-allergic drugs in Japan

Purification and amino-acid sequence of a nerve growth factor from the venom of Vipera russelli russelli.

Biochimica et biophysica acta·1992

Genomic structure of the human caldesmon gene.

Proceedings of the National Academy of Sciences of the United States of America·1992

[A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·1992

Crosslinking of proteins in acetylcholine receptor-rich membranes from Torpedo californica: relation of 43-kD protein and Torpedo dystrophin to acetylcholine receptor.

Biochemistry international·1992

Application of ozone disinfection to remove Enterococcus seriolicida, Pasteurella piscicida, and Vibrio anguillarum from seawater.

Applied and environmental microbiology·1992

Absence of activating mutations in the transmembrane domain of the c-erbB-2 protooncogene in human lung cancer.

Japanese journal of cancer research : Gann·1992

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Orphan drug regulation: a global comparison of the United States Food and Drug Administration, European Medicines Agency, and Japanese Pharmaceuticals and Medical Devices Agency approaches.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026

Distinct EEG functional network alterations in Parkinson's disease and multiple system atrophy.

NeuroImage. Clinical·2026

Hyaluronic acid in Peyronie's disease: focus on injection procedures and clinical practice.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026

Current perspectives on the pharmacologic treatment of boys and adolescents with congenital hypogonadotropic hypogonadism.

Expert opinion on pharmacotherapy·2026

Wound/Pressure Ulcer/Burn Guidelines (2023)-3 Guidelines for the Diagnosis and Treatment of Diabetic Skin Ulcer/Gangrene (3rd Edition).

The Journal of dermatology·2026

A New Class of Drugs Approved in the United States for Hypertension: Aldosterone Synthase Inhibitors.

The American journal of medicine·2026

Related Experiment Videos

Evaluation of oral anti-allergic drugs in Japan

Related Concept Videos

Purification and amino-acid sequence of a nerve growth factor from the venom of Vipera russelli russelli.

Genomic structure of the human caldesmon gene.

[A case of gastric carcinoma with peritonitis carcinomatosa responding remarkably to etoposide, adriamycin and cisplatin (EAP) therapy].

Crosslinking of proteins in acetylcholine receptor-rich membranes from Torpedo californica: relation of 43-kD protein and Torpedo dystrophin to acetylcholine receptor.

Application of ozone disinfection to remove Enterococcus seriolicida, Pasteurella piscicida, and Vibrio anguillarum from seawater.

Absence of activating mutations in the transmembrane domain of the c-erbB-2 protooncogene in human lung cancer.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Orphan drug regulation: a global comparison of the United States Food and Drug Administration, European Medicines Agency, and Japanese Pharmaceuticals and Medical Devices Agency approaches.

Distinct EEG functional network alterations in Parkinson's disease and multiple system atrophy.

Hyaluronic acid in Peyronie's disease: focus on injection procedures and clinical practice.

Current perspectives on the pharmacologic treatment of boys and adolescents with congenital hypogonadotropic hypogonadism.

Wound/Pressure Ulcer/Burn Guidelines (2023)-3 Guidelines for the Diagnosis and Treatment of Diabetic Skin Ulcer/Gangrene (3rd Edition).

A New Class of Drugs Approved in the United States for Hypertension: Aldosterone Synthase Inhibitors.

Related Experiment Videos

Evaluation of oral anti-allergic drugs in Japan

Related Concept Videos

Related Articles